R

Redhill Biopharma Ltd
D

RDHL

5.70500
USD
0.11
(1.88%)
مغلق
حجم التداول
193
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
7,305,475
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -0.290
    (-0.43%)
    66.620 USD
    B
    BCRX
    0.38000
    (5.38%)
    7.44000 USD
    BNTX
    BNTX
    -0.660
    (-0.59%)
    111.980 USD
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    I
    INO
    0.17000
    (8.85%)
    2.09000 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    MRNA
    MRNA
    0.310
    (0.92%)
    34.050 USD
    N
    NNVC
    -0.02000
    (-1.67%)
    1.18000 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    REGN
    REGN
    -11.37
    (-1.64%)
    681.49 USD
    V
    VSTM
    0.04000
    (0.76%)
    5.33000 USD
    المزيد
الأخبار
المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company alsocommercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.